Cargando…

Toll gates: An emerging therapeutic target

Innate immune system forms the first line of defense against microbial infections, as it exerts an immediate response. Innate immunity works through Toll-like receptors (TLRs) which functions as primary sensors of pathogens. TLR activates multiple signaling cascades leading to the induction of genes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maheaswari, Rajendran, Sivasankar, Kiruthika, Subbarayan, Sathya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296450/ https://www.ncbi.nlm.nih.gov/pubmed/25624622 http://dx.doi.org/10.4103/0972-124X.147398

Ejemplares similares

Is immunesenescence a contributing factor for periodontal diseases?
por: Rajendran, Maheaswari, et al.
Publicado: (2013)

Polymerase chain reaction: A molecular diagnostic tool in periodontology
por: Maheaswari, Rajendran, et al.
Publicado: (2016)

Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
por: Javaid, Nasir, et al.
Publicado: (2019)

National guidelines for gene therapy product (2019): A road-map to gene therapy products development and clinical trials
por: Sivagourounadin, Kiruthika, et al.
Publicado: (2021)

Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
por: Muccioli, Maria, et al.
Publicado: (2012)

Recent clinical trends in Toll‐like receptor targeting therapeutics
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2018)

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
por: Abarca-Merlin, D. M., et al.
Publicado: (2019)

Voltage gated sodium channels as therapeutic targets for chronic pain
por: Ma, Renee Siu Yu, et al.
Publicado: (2019)

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders
por: Ashayeri Ahmadabad, Rezan, et al.
Publicado: (2021)

HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
por: Ren, Wenxuan, et al.
Publicado: (2023)

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease
por: Wu, Linyu, et al.
Publicado: (2022)

From Toxins Targeting Ligand Gated Ion Channels to Therapeutic Molecules
por: Nasiripourdori, Adak, et al.
Publicado: (2011)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Knowledge, Attitude, and Practice of Materiovigilance among Nurses at a Tertiary Care Hospital in South India: A Cross-Sectional Study
por: Sivagourounadin, Kiruthika, et al.
Publicado: (2022)

Toll-like receptor 2: therapeutic target for gastric carcinogenesis
por: McCormack, William, et al.
Publicado: (2012)

Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
por: Farooq, Mariya, et al.
Publicado: (2021)

Toll‐like receptor 4: A promising therapeutic target for pneumonia caused by Gram‐negative bacteria
por: Ding, Junying, et al.
Publicado: (2019)

Toll-Like Receptor Signaling Pathways—Therapeutic Opportunities
por: Zhu, Jiankun, et al.
Publicado: (2010)

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
por: Yang, Jing, et al.
Publicado: (2015)

The emerging role of Toll-like receptor 4 in myocardial inflammation
por: Yang, Y, et al.
Publicado: (2016)

Emerging roles of Toll-like receptor 9 in cardiometabolic disorders
por: Nishimoto, Sachiko, et al.
Publicado: (2020)

Emerging therapeutic targets in esophageal adenocarcinoma
por: Gaur, Puja, et al.
Publicado: (2016)

Targeting Toll-Like Receptors for Treatment of SLE
por: Horton, Christopher G., et al.
Publicado: (2010)

Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2023)

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems
por: Li, Haixia, et al.
Publicado: (2021)

Toll-like Receptor 2: A Novel Therapeutic Target for Ischemic White Matter Injury and Oligodendrocyte Death
por: Choi, Jun Young, et al.
Publicado: (2017)

Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
por: Gosu, Vijayakumar, et al.
Publicado: (2012)

Activin signaling as an emerging target for therapeutic interventions
por: Tsuchida, Kunihiro, et al.
Publicado: (2009)

FXR an emerging therapeutic target for the treatment of atherosclerosis
por: Mencarelli, Andrea, et al.
Publicado: (2010)

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
por: Schneider, Susanne A., et al.
Publicado: (2020)

The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies
por: Pagiatakis, Christina, et al.
Publicado: (2021)

Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma
por: Miwa, Shinji, et al.
Publicado: (2022)

Cohesin Mutations in Cancer: Emerging Therapeutic Targets
por: Antony, Jisha, et al.
Publicado: (2021)

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues
por: Subbarayan, Karthikeyan, et al.
Publicado: (2021)

Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's Syndrome
por: Kiripolsky, Jeremy, et al.
Publicado: (2018)

LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
por: Karakaidos, Panagiotis, et al.
Publicado: (2019)

Emergency Pancreaticoduodenectomy for Exsanguinating Ampullary Malignancy
por: Subbarayan, Ravikumar, et al.
Publicado: (2020)

Fe-S Clusters Emerging as Targets of Therapeutic Drugs
por: Vernis, Laurence, et al.
Publicado: (2017)

Podoplanin: An emerging cancer biomarker and therapeutic target
por: Krishnan, Harini, et al.
Publicado: (2018)

Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas
por: Hey, Grace, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4b8n3mgvk0hv4ok5bgm28jd91